PR NewsWire | Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer’s Disease-Green Valley

CN

News Reports

Products

PR NewsWire | Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer’s Disease

Date：2019-11-04

The PR NewsWire.png

ShareTo：

Previous Page：

Economics Times | China okays sale of first home-grown Alzheimer’s drug

Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer's Disease